Tatva Chintan Pharma Chem consolidated net profit rises 901.94% in the March 2026 quarter
(18 May 2026)

Back
Net profit of Tatva Chintan Pharma Chem rose 901.94% to Rs 10.32 crore in the quarter ended March 2026 as against Rs 1.03 crore during the previous quarter ended March 2025. Sales rose 24.36% to Rs 134.14 crore in the quarter ended March 2026 as against Rs 107.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 636.43% to Rs 42.05 crore in the year ended March 2026 as against Rs 5.71 crore during the previous year ended March 2025. Sales rose 32.18% to Rs 505.86 crore in the year ended March 2026 as against Rs 382.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales134.14107.86 24 505.86382.71 32
OPM %20.978.30 -18.428.94 -
PBDT26.349.29 184 93.8635.24 166
PBT16.592.03 717 57.017.58 652
NP10.321.03 902 42.055.71 636

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew